Cochrane review finds uncertain benefits of drugs for Friedreich ataxia with low-certainty evidence
Cochrane review finds little benefit for drugs treating Friedreich ataxia
This Cochrane systematic review evaluated pharmacological treatments for people with genetically-confirmed Friedreich ataxia. The analysis i…
A major review of eight studies found that most drugs for Friedreich ataxia likely make little difference to key symptoms compared to placeb…
Longitudinal multimodal MRI identifies Friedreich ataxia progression subtypes in 111 patients and controls
Three distinct brain patterns linked to Friedreich ataxia progression
This observational cohort study analyzed 111 participants, including 54 Friedreich ataxia patients and 57 controls, using longitudinal multi…
Three distinct brain patterns linked to Friedreich ataxia progression were identified using MRI scans and genetic data in patients.